9 glioblastoma S UPRATENTORIAL tumors comprise approximately 40% of brain tumors in children; of these about one-half are of neuroectodermal origin. ~ Supratentorial tumors can be subclassified into a number of distinct anatomico-clinical groups. The clinical presentation, neuroradiological findings, and treatment approach depend heavily on the anatomical location of a tumor; for example, certain tumors are considered resectable whereas others are thought to be "untouchable. " We retrospectively analyzed 60 patients with thalamic tumors seen at The Hospital for Sick Children between 1951 and 1983 to determine the long-range outcome of these patients and to suggest therapeutic guidelines.
Summary of Cases

Clinical Data
Since 1951, 60 children with thalamic tumors were treated at the Hospital for Sick Children. There were 30 males and 30 females. Thirty-two tumors were on the left side and 28 on the right. The age of the patients at first presentation ranged from 5 months to 18 years (mean 7.7 years). The duration of symptoms before diagnosis ranged from 1 day to 3 years. Twenty-three patients (38%) presented with a history of less than 1 month, 22 (37%) with a history of 1 to 4 months, 11 (18%) with a history of 5 to 12 months, and four (7%) with a history of 1 to 3 years. The most common presenting symptoms and signs were referable to increased intracranial pressure or to a focal neurological deficit (Table 1) .
Diagnostic Studies
The criteria for inclusion of patients in this review were based on neuroradiological studies. Tumors thought to be arising primarily from the thalamus (and not secondarily involving this region by local extension) were included. We excluded all tumors considered to be primarily arising within the pineal region, brain stem, optic apparatus, hypothalamus, or lateral and Vascularity Tumor  Tumor   yes  5  5  no  5  8 third ventricles, and secondarily involving the thalamus. Tumors arising within the basal ganglia and extending contiguously into the thalamus were included as thalamic tumors. Thirty-three patients were first seen and investigated in the era before computerized tomography (CT) became available (1951 to 1973) and 27 in the CT era (1974 to 1983). In the pre-CT era, most patients had skull x-ray films, air encephalography or ventriculography, and angiography. Five patients also had radionuclide brain scans. Since 1974, besides CT scans, 19 (70%) of 27 patients underwent cerebral angiography. The initial CT scan demonstrated a predominantly solid mass in most cases; in seven (26%) of 27 cases there was also a recognizable, presumably cystic, component. Six patients who did not undergo CT scanning were found to have cystic tumors at surgery; therefore a total of 13 patients (22%) had a significant cystic component in their tumor. Of the 13 tumors with cystic components, two were malignant, six were benign, and five had no tissue diagnosis. The CT scan enhancement pattern for 21 histologically verified tumors (Table 2) had no predictive value regarding histology (Fig. 1) . The child with 1-month history of headache and hemiparesis. This densely enhancing tumor was a pilocytic astrocytoma.
Angiographic vascularity in 23 verified tumors
Benign Malignant
presence of angiographic vascularity in 23 histologically verified tumors (Table 3 ) also had no predictive value regarding histology.
Treatment
Thirty-six patients (60%) required placement of cerebrospinal fluid (CSF) shunts at the time of first presentation, or shortly after treatment of the tumor. Initial shunts inserted included 24 ventriculoperitoneal, nine ventriculocisternal, two ventriculoatrial, and one lumboperitoneal system. The surgical history summarizing direct attack on the tumor is presented in Table 4 . The term "definitive surgical procedure" refers to the most aggressive operation performed on the patient; 16 had no surgical procedure directed at their tumor, 37 patients underwent one surgical procedure on their tumor, and seven had two operations on their tumor. Of the 44 patients who had one or more operations on their tumor, the definitive surgical procedure was needle biopsy in three, open biopsy in 20, and partial resection in 21. Macroscopic total resection was achieved in only one case. The transcortical route was employed in 16 biopsies and 15 resections. The transcallosal route was utilized in four biopsies and six resections. There were no operative deaths (death within 30 days of surgery), but seven patients died between 32 days and 6 months after surgery on their tumor. Another three patients who were not operated on died within 6 months of first presentation.
Three patients were made worse neurologically by surgical intervention (for a morbidity rate of 7%). At first evaluation after treatment, 24 (40%) of the 60 patients were severely disabled (such as by hemiplegia, dysphasia, or dementia), 20 (33%) were moderately disabled (such as by moderate hemiparesis, personality change, or decreased visual acuity), and 16 (27%) were normal or with only minor disability (such as sixth nerve paresis, mild hemiparesis, or visual field defect). Forty-four patients (73%) received radiation therapy during the initial treatment period. The dose given ranged from 35 to 55 Gy, with a mean of 49.30 Gy (1 Gy = 100 rads). Three patients received a second course of radiation for management of clinical deterioration 1 to 3 years after the initial treatment. The total dose in these three patients was 80.00 Gy, 77.48 Gy, and 82.50 Gy, respectively. Only one patient received spinal axis irradiation (30.00 Gy) along with cranial irradiation. Eight patients (13%) received a course of systemic chemotherapy.
Pathology
All surgical and postmortem slides pertaining to patients with thalamic tumors were assembled and reviewed without knowledge of the original diagnosis or opinion. In selected cases, the peroxidase-antiperoxidase method was used to stain sections (formalin-fixed, paraffin-embedded tissue) for glial fibrillary acidic protein to confirm that the tumor was of astrocytic derivation. 22 Astrocytic tumors were diagnosed as either astrocytomas, malignant astrocytomas, or glioblastoma multiforme. Astrocytomas included both pilocytic and lowgrade fibrillary types. Astrocytic tumors with mitoses, increased cellularity, and cellular pleomorphism were diagnosed as malignant astrocytomas. If the same features plus necrosis and endothelial proliferation were present, then the tumor was diagnosed as glioblastoma multiforme. When the biopsied tissue was insufficient for a firm diagnosis, unsuitable for histological examination, or was normal, the designation was "no histological diagnosis." Thirty-seven patients had histological confirmation of their tumor by surgical biopsy. A further four had histological confirmation of their tumor at autopsy; therefore, 41 (68%) of the 60 tumors in this series had known pathology (Table 5) . Forty-four patients in this series underwent some type of surgical approach on their tumor, and the biopsy findings were confirmed in 37 (84 %). The seven failed biopsies included two needle biopsies, two "explorations," and three actual biopsies by open craniotomy. In three patients, inadequate tissue was obtained at biopsy and, in the other four, abnormal tissue was obtained, but definitive histological tumor diagnosis could not be made from it.
All 41 histologically confirmed tumors in our series were of neuroectodermal origin. The majority were astrocytic, and the full histological spectrum from lowgrade (pilocytic) astrocytomas, indistinguishable from those arising in optic nerves and cerebellum, to malignant tumors (malignant astrocytoma and glioblastoma) is represented. Of the 41 verified tumors, 21 (51%) were histologically low-grade tumors, and 20 (49%) were malignant.
Three modes of tumor extension and spread were observed in this series: 1) along white matter pathways; 2) subependymal; and 3) via CSF pathways. At autopsy, tumor extension along white matter pathways was seen frequently, both horizontally, to involve the optic apparatus and contralateral thalamus, and vertically, to involve the brain stem. Two patients had histologically proven extension of tumor in the subependymal region, with or without rupture into the ventricular system at a distance from the primary tumor. Two patients also had definite CSF metastases as indicated by sheets of tumor cells surrounding the spinal cord in the subarachnoid space. Tumor spread of the three kinds outlined was not confined to patients with malignant neoplasms (Fig. 2) . * Excluded from these data are the two patients with tuberous sclerosis.
t Difference in survival between benign and malignant group highly significant (p < 0.0001) by Gehan-Wilcoxon, log rank, and likelihood ratio tests. In two cases, the t u m o r progressed histologically over a span of years to a more malignant grade. This was not considered to be due to sampling error at the first surgery because, in both cases, the initial operation consisted of partial t u m o r removal (that is, diagnosis was not limited to biopsy material). The tendency of astrocytomas to dedifferentiate is well recognized. 21 In one of the two cases, the histological progression was paralleled by marked radiological and clinical deterioration of the patient (Fig. 3) .
Outcome
Fifty-nine patients were available for follow-up review to time of death or to December, 1983. Only one patient was lost to current follow-up review: when he t There was a statistically significant (p < 0.02) improvement in survival in irradiated compared to non-irradiated patients, as tested by Gehan-Wilcoxon and likelihood ratio tests. There was no statistically significant improvement in survival with tumor resection, as tested by Gehan-Wilcoxon, log rank, and likelihood ratio tests. was last examined, he was well 10 years after treatment of an astrocytoma. Survival data are summarized in Tables 6 to 10 . Overall, 40 patients died, with a mean survival time of 2.6 years. Twenty children are still alive after a mean of 9.1 years. Every patient with a malignant t u m o r died; whereas, eight (44%) of the 19 patients with benign tumors are alive (Table 6) . Of the eight patients with benign tumors still surviving after a mean time of 7.2 years (longest survivor 20 years), seven are normal or have a minor disability. One child is moderately disabled. Results of treatment of benign tumors are shown in Table 7 ; there appears to be no statistical difference in the rate of survival between patients with resected tumors compared with those with biopsied tumors or between patients who did or did not undergo irradiation. Table 8 demonstrates results of different treatment groups with malignant tumors; a weak statistical difference was found between survival times of irradiated and non-irradiated patients. Mean survival time of patients harboring malignant tumors was 1.1 years. Three children lived longer than 2 years (2.7, 4, and 5 years) but, typically, early tumor recurrence became manifest both clinically and radiologically, regardless of therapy (Fig. 4) . Results of treatment of unverified tumors are shown in Table 9 . Quality of life of all survivors is outlined in Table 10 . All but one survivor with benign tumors are in good condition neurologically; one child is moderately disabled. Of the 12 surviving children with unverified tumors, seven are in good condition, two are moderately disabled, and three are in poor condition neurologically.
Discussion
The management of thalamic and basal ganglion tumors presents special problems to the neurosurgeon and oncologist. The two main issues are the role of surgery and the role of radiation in the management of these patients. The problem of correct management is further compounded by our failure to be able accurately to predict tumor histology preoperatively based on radiological investigations. Specifically, as demonstrated in our case material, the presence of CT enhancement, a cyst on the CT scan, or vascular blush on angiography all fail to help predict whether the tumor is low-grade or malignant.
We recommend the establishment of a histological diagnosis in all cases of thalamic tumor, not only to determine whether the lesion is a low-grade or malignant neuroectodermal tumor, but also to exclude the possibility of a non-neuroectodermal tumor in this location, which has been described. 12'4 The establishment of a histological diagnosis will dictate whether radiation is indicated, and also what form of radiation (that is, cranial only or craniospinal) should be employed. The method of obtaining a biopsy is variable. With the advent of improvements in CT scanning and stereotaxic technology, a stereotaxic needle biopsy is favored by some.l'20 '24 We favor open biopsy by craniotomy for three reasons: 1) it is safer in our opinion; 2) there is a greater chance of obtaining representative biopsy material; and 3) one is afforded the opportunity of carrying out a partial resection of the lesion. Regarding resection of thalamic tumors, we believe that radical excision of these lesions is seldom achieved safely, contrary to some reports in the literature. Arseni 2 advocated radical surgery on thalamic tumors, but his mortality rate was severe. Greenwood 7 stipulated that aggressive surgical resection is indicated only for thalamic tumors of low-grade histology. Ehn? reported 52
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transcallosal procedures, of which 11 were for thalamic neuroectodermal neoplasms. Of nine tumors that were totally or subtotally removed, the patients experienced permanent worsening of their neurological status in six cases.
Although we cannot prove that partial resection of thalamic tumors produces a significant improvement in survival, we believe that partial resection of thalamic tumors should be attempted if deemed safe. This will decrease tumor bulk, which may open up CSF pathways, and may enhance the effectiveness of postoperative adjuvant treatment with radiation. Surgical exploration also affords the opportunity to fenestrate the septum pellucidum in cases where a foramen of Monro is obstructed, thus obviating the need for bilateral shunts in a hydrocephalic child. In our surgical cases, three patients were clinically worse after surgery: one after a transcortical tumor biopsy, one after a transcallosal biopsy, and one after a transcallosal tumor resection. The surgical morbidity rate was therefore 7% (three of 41 cases). Only one patient was thought to have had a gross total tumor removal. We therefore conclude that thalamic tumors can be surgically approached and partially resected safely in approximately 50% of cases; of the remaining cases, open biopsy can be safely performed in the majority.
As far as radiation therapy is concerned, we disagree with the policy of irradiating thalamic tumors without histological diagnosis, as advocated by several authors. 4"1~ For malignant tumors we cannot comment conclusively on the efficacy of radiation therapy based on our series. Although there is a statistically significant difference in survival between the irradiated and non-irradiated groups, the two groups are widely disparate in size and, furthermore, the two non-irradiated patients may have been preselected not to receive radiation therapy because of their poor clinical status (Table 8) . However, based on the poor outlook for these patients and the generally accepted prolongation of survival of adults with malignant astrocytomas and glioblastomas by irradiation, 25 we recommend a course of cranial radiation therapy for all children with malignant thalamic tumors. Furthermore, for patients with tumors prone to metastasize through CSF pathways, such as primitive neuroectodermal tumors (PNET), 9' 13 a course of spinal irradiation should also be seriously considered.
The real controversy regarding irradiation applies to the management of children with low-grade tumors. A number of reports demonstrate a beneficial effect of radiation therapy on incompletely excised astrocytomas. 6' 15' 16 In our series, we find no statistically significant improvement in survival in patients with astrocytomas who received a course of cranial irradiation (Table 7) . It is evident, however, that there is a subpopulation of low-grade astrocytomas that behave in a very benign manner and may remain dormant for years; in our series, 10 of 19 patients with benign tumors lived longer than 5 years and four of these did not receive radiation therapy (two died after 8 and 14 years, and two are alive after 7 and 10 years). We therefore believe that it would be reasonable not to irradiate patients with astrocytomas, but to follow these patients clinically and with CT and reserve radiation therapy for documented tumor progression.
Alternatives to conventional external cranial irradiation may be well suited for deep thalamic tumors, either low-grade or malignant. Interstitial irradiation has been employed for these tumors, the rationale being that thalamic tumors are deep, relatively well localized, and well suited for delivery of large localized doses of radiation from an interstitial radioactive implant. 3' 8'9
The theoretical advantages and radiobiological considerations for interstitial irradiation have been summarized, 3 but superiority of this modality in treating deep cerebral tumors has not been conclusively demonstrated.
Conclusions
1. The mainstay of the radiological investigation of a patient with a thalamic tumor is the CT scan. The presence of enhancement or cyst on CT scanning has no predictive value regarding histology of the tumor. The presence of a vascular blush on angiography also has no predictive value regarding histology, but angiography may be useful in planning parasagittal craniotomy. Perhaps preoperative arteriography (if desired) can be replaced by safer venous studies, such as digital subtraction venous angiography.
2. The treatment of thalamic tumors remains controversial. We believe that all thalamic tumors should be verified histologically. At our institution at this time, open biopsy by craniotomy is preferred over needle biopsy (with or without stereotaxic guidance). Partial resection of the tumor is considered worthwhile when deemed safe. The transcallosal approach is recommended in cases where a major portion of the tumor protrudes into the lateral ventricle. A transcortical approach is favored when minimal impingement on the ventricular system is demonstrated on CT scanning.
3. Adjuvant therapy following surgery depends on the histological nature of the tumor. Low-grade neoplasms, such as astrocytoma, mixed glioma, or oligodendroglioma, have unpredictable biological and growth characteristics. We believe it is desirable not to irradiate patients harboring low-grade tumors initially. Radiation therapy can be given at a later date if tumor progression is documented clinically and radiologically.
4. Malignant tumors, such as glioblastoma, malignant astrocytoma, or PNET, have a dismal prognosis. We recommend cranial irradiation for all patients harboring a malignant tumor and spinal irradiation as well for those with a tumor that tends to seed through CSF pathways, such as PNET. 9'13 The role of chemotherapy in these lesions has not been conclusively defined. The poor outlook for these patients indicates that attention must be focused on other modalities, such as interstitial radiation, heat therapy, immunotherapy, and photodynamic therapy.
